SurgoCap Partners: Stock Portfolio, Performance and Latest Trades

Holdings history from Q4 2023Latest report: Q2 2026, filed August 14, 2026SEC filings (CIK 1960830)
13F portfolio value
$3.1B
13 holdings at Q2 2026

Get an email when SurgoCap Partners files a new 13F report

Free, no account needed. Unsubscribe with one click.

SurgoCap Partners' portfolio

As of Q2 2026, filed August 14, 2026 · prices as of October 8, 2026

CompanyShare of portfolioAverage buy priceReturnCurrent priceValue nowSharesHeld sinceLast quarterLast change
14.0%$244.54+87.3%$457.99$415.9M908,064Q3 2025Reduced −18%Q2 2026
13.7%$187.74+106%$387.10$265.7M686,473Q3 2024Reduced −43%Q2 2026
11.0%$245.80+40.3%$344.86$333.2M966,080Q3 2025Reduced −35%Q2 2026
9.68%$268.51+22.2%$328.00$348.7M1,063,218Q4 2023Added +4.2%Q2 2026
9.55%$43.43−17.7%$35.74$267.6M7,487,507Q1 2026Added +23%Q2 2026
9.21%$593.19+56.8%$930.25$350.6M376,870Q4 2023Added +8.1%Q2 2026
8.34%$101.12+5.9%$107.08$197.9M1,848,315Q2 2026NewQ2 2026
6.58%$120.60+26.7%$152.83$121.8M797,181Q1 2026Reduced −7.1%Q2 2026
6.26%$321.30+16.7%$375.10$211.6M564,207Q1 2026Added +96%Q2 2026
3.87%$665.30−40.1%$398.66$59.8M149,983Q2 2026NewQ2 2026
3.46%$10.83+42.0%$15.38$123.1M8,000,728Q4 2023Reduced −19%Q2 2026
3.30%$526.80−21.1%$415.41$106.7M256,963Q4 2025Reduced −23%Q2 2026
1.01%$49.06−20.8%$38.84$24.8M638,725Q2 2026NewQ2 2026

Q4 2023 is the first report we have for this investor, so there is nothing to compare it with.

SurgoCap Partners' portfolio by sector

Share of the stock portfolio at Q2 2026.

22%Technology
SectorShareValueHoldings
Technology22%$691.7M2
Health Care22%$682.3M3
Materials21%$658.4M3
Financials19%$600M3
Communication Services11%$341.3M1
Industrials3.9%$119.8M1

Portfolio performance: SurgoCap Partners vs. benchmarks

Your result if you had bought each reported portfolio on the day it was made public and held it until the next report, against the S&P 500 and Nasdaq-100.

  • You, copying after each 13F filing – estimated value
  • S&P 500
  • Nasdaq-100
−20%0%+20%+40%+60%+80%AprOctAprOctAprOct+75%Nasdaq-100+60%S&P 500+59%You, copying
Feb 14, 2024 to Oct 8, 2026, buying on 13F filing dates; prices adjusted for dividends and splits.
Total returnPer year
You, copying after each 13F filing – estimated value+59.5%+19.3%
S&P 500+60.3%+19.5%
Nasdaq-100+75.1%+23.6%

SurgoCap Partners' most traded stocks

Quarters with a buy or a sell, all reports since Q4 2023.

CompanyQuarters boughtQuarters soldLast change
73Q2 2026
46Q2 2026
46Q2 2026
45Q1 2026
44Q2 2026
53Q2 2026
53Q1 2026
44Q1 2026
25Q4 2025
32Q1 2026
32Q1 2025
22Q2 2026
31Q2 2026
13Q2 2026
22Q4 2025